Related Party Transactions (Details Narrative) - USD ($)													1 Months Ended	12 Months Ended
	Aug. 29, 2022	Aug. 09, 2022	Jul. 26, 2022	May 17, 2022	May 17, 2022	Mar. 09, 2022	Feb. 28, 2022	Feb. 28, 2022	Oct. 13, 2021	Mar. 18, 2021	Mar. 18, 2021	Oct. 31, 2017	Nov. 30, 2021	Dec. 31, 2023	Dec. 31, 2022	Jul. 02, 2022	Feb. 18, 2022	Mar. 02, 2020
Marketable securities														$ 10,000,000.0
Unrealized gain on investment														(17,325,000)	$ (17,976,000)
Principal amount														55,227,000
Interest expense														553,000	126,000
Number of shares of common stock, value														$ 268,000	$ 17,405,000
Conversion of stock														140,264,240	139,017,000
Stock issued for acquisition				17,570,948
Long term portion of notes receivable														$ 8,772,000	$ 11,719,000
Note 11 [Member]
Debt instrument, face amount	$ 100,000		$ 1,000,000
Debt instrument interest rate	8.00%		8.00%
Maturity date	Aug. 29, 2025		Jul. 26, 2024
Notes and loans receivable gross current														939,000	924,000
Unamortized origination fees														20,000	66,000
Long term portion of notes receivable														24,000	76,000
Note 10 [Member]
Debt instrument, face amount	$ 100,000
Debt instrument interest rate	8.00%
Maturity date	Aug. 29, 2025
Notes and loans receivable gross current														100,000	100,000
Long term portion of notes receivable														24,000	76,000
BMIC Loan [Member]
Debt instrument, face amount									$ 3,000,000					547,000	3,000,000
Maturity date									Oct. 12, 2022
Wilson Loan [Member]
Debt instrument, face amount									$ 3,000,000					2,131,000	3,008,000
Maturity date									Oct. 12, 2022
Impact Oncology PTE Ltd. [Member]
Investment owned balance shares										2,480,000	2,480,000
Consideration transferred										$ 2,480,000	$ 2,480,000
Options to purchase additional shares										250,000
Alset Note [Member]
Debt instrument, face amount				$ 8,350,000	$ 8,350,000								$ 8,350,000		8,350,000
Debt instrument interest rate													8.00%
Debt instrument maturity date, description													matures in December 2023
Principal amount													$ 8,805,000		8,805,000
Shares issued for convertible debt				21,366,177	21,366,177
Accrued unpaid interest				$ 119,000	$ 119,000										119,000
Interest expense														$ 677,000	346,000
Alset International Limited [Member]
Investment owned balance shares														127,179,291
Warrants percentage														4.00%
Marketable securities														$ 3,269,000	3,319,000
Unrealized gain on investment														$ 50,000	$ 1,590,000
American Medical REIT Inc. [Member] | Unsecured Promissory Note [Member]
Debt instrument, face amount																		$ 200,000
Debt instrument interest rate																		8.00%
Exercise price of warrants																		$ 5.00
Warrants and rights outstanding																		$ 200,000
Impact Oncology PTE Ltd. [Member]
Investment owned balance shares										2,480,000	2,480,000
Alset EHome International Inc [Member]
Debt instrument, face amount				$ 8,350,000	$ 8,350,000
Shares issued for convertible debt				21,366,177	21,366,177
Alset EHome International Inc [Member] | Stock Purchase Agreement [Member]
Issuance of common stock, net of expenses, shares						3,986,877	44,619,423	44,619,423
Issued price per share							$ 0.3810	$ 0.3810
Number of shares of common stock, value						$ 1,519,000	$ 17,000,000	$ 17,000,000
Payments for proceeds from previous acquisition							$ 1,519,000
Alset EHome International Inc [Member] | Stock Purchase Agreement [Member] | Minimum [Member]
Issuance of common stock, net of expenses, shares							3,986,877
HWH International Inc [Member]
Debt instrument, face amount												$ 50,000
Issued price per share												$ 0.15
Conversion of stock												333,333
Warrants to purchase												333,333
Cancelleation of warrants and notes		$ 78,635.62
True Partners Capital Holdings Limited [Member]
Stock issued for acquisition				62,122,908
Number of shares exchanged				17,570,948
Alset EHome [Member]
Share price																$ 0.34	$ 0.41